Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Maurer, I.
and
Volz, H.-P.
1999.
Lipid supplementation in schizophrenia.
British Journal of Psychiatry,
Vol. 175,
Issue. 3,
p.
287.
Swain, S.
and
Pradhan, C.
1999.
[No Title].
British Journal of Psychiatry,
Vol. 175,
Issue. 1,
p.
88.
Horrobin, D. F.
1999.
Lipids and schizophrenia.
British Journal of Psychiatry,
Vol. 175,
Issue. 1,
p.
88.
Hudson, C.
1999.
Cytosolic phospholipase A2 gene in schizophrenia.
British Journal of Psychiatry,
Vol. 175,
Issue. 2,
p.
190.
Brown, Alan S.
2000.
Lipids and chronic central nervous system disease.
Current Opinion in Clinical Nutrition and Metabolic Care,
Vol. 3,
Issue. 2,
p.
95.
Tachikawa, Hirokazu
Harada, Shoji
Kawanishi, Yoichi
Okubo, Takehito
and
Suzuki, Toshihito
2001.
Linked polymorphisms (–333G>T and –286A>G) in the promoter region of the CCK-A receptor gene may be associated with schizophrenia.
Psychiatry Research,
Vol. 103,
Issue. 2-3,
p.
147.
Fevre, P. D. Le
2001.
Improving the Physical Health of Patients with Schizophrenia: Therapeutic Nihilism or Realism?.
Scottish Medical Journal,
Vol. 46,
Issue. 1,
p.
11.
Fukuzako, Hiroshi
2001.
Neurochemical Investigation of the Schizophrenic Brain by in Vivo Phosphorus Magnetic Resonance Spectroscopy.
The World Journal of Biological Psychiatry,
Vol. 2,
Issue. 2,
p.
70.
Assies, Johanna
Lieverse, Ritsaert
Vreken, Peter
Wanders, Ron J.A
Dingemans, Peter M.J.A
and
Linszen, Donald H
2001.
Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group.
Biological Psychiatry,
Vol. 49,
Issue. 6,
p.
510.
Chen, Chwen Cheng
Lu, Feng-Hwa
Wu, Jin-Shang
and
Chang, Chih-Jen
2001.
Correlation between serum lipid concentrations and psychological distress.
Psychiatry Research,
Vol. 102,
Issue. 2,
p.
153.
Vaille-Perret, E
Motta, C
and
Jalenques, I
2002.
Étude de l’évolution clinique et des modifications de fluidité membranaire chez des patients schizophrènes traités par neuroleptiques.
Annales Médico-psychologiques, revue psychiatrique,
Vol. 160,
Issue. 1,
p.
58.
Ponizovsky, Alexander M.
Barshtein, Gregory
and
Bergelson, Lev D.
2003.
Biochemical Alterations of Erythrocytes as an Indicator of Mental Disorders: An Overview.
Harvard Review of Psychiatry,
Vol. 11,
Issue. 6,
p.
317.
Fox, Helen
Ross, Brian M.
Tocher, Douglas
Horrobin, David
Glen, Iain
and
St. Clair, David
2003.
Degradation of specific polyunsaturated fatty acids in red blood cells stored at −20°C proceeds faster in patients with schizophrenia when compared with healthy controls.
Prostaglandins, Leukotrienes and Essential Fatty Acids,
Vol. 69,
Issue. 5,
p.
291.
Papadimitriou, George N.
Dikeos, Dimitris G.
Souery, Daniel
Del-Favero, Jurgen
Massat, Isabelle
Avramopoulos, Dimitrios
Blairy, Sylvie
Cichon, Sven
Ivezic, Sladjana
Kaneva, Radka
Karadima, Georgia
Lilli, Roberta
Milanova, Vihra
N??then, Markus
Oruc, Lilijana
Rietschel, Marcella
Serretti, Alessandro
Van Broeckhoven, Christine
Stefanis, Costas N.
and
Mendlewicz, Julien
2003.
Genetic association between the phospholipase A2 gene and unipolar affective disorder: a multicentre case???control study.
Psychiatric Genetics,
Vol. 13,
Issue. 4,
p.
211.
Lee, Sang
Gura, Kathleen M.
Kim, Sendia
Arsenault, Danielle A.
Bistrian, Bruce R.
and
Puder, Mark
2006.
Current Clinical Applications of Ω‐6 and Ω‐3 Fatty Acids.
Nutrition in Clinical Practice,
Vol. 21,
Issue. 4,
p.
323.
Rassart, Eric
Desmarais, Frederik
Najyb, Ouafa
Bergeron, Karl-F.
and
Mounier, Catherine
2020.
Apolipoprotein D.
Gene,
Vol. 756,
Issue. ,
p.
144874.
Porozova, Natalia
Danilova, Elena
Senshinov, Igor
Tsakalof, Andreas
and
Nosyrev, Alexander
2022.
Experiences and Perspectives of GC-MS Application for the Search of Low Molecular Weight Discriminants of Schizophrenia.
Molecules,
Vol. 28,
Issue. 1,
p.
324.
eLetters
No eLetters have been published for this article.